Lab & Pharmacy Supply Management

Photo 113658209 © Anyaberkut | Dreamstime.com
Lab & Pharmacy Supply Management

Children’s Nebraska Expands Medline Partnership

Feb. 7, 2024
Medline was awarded a laboratory prime vendor agreement
Photo by Alex Green from Pexels
Photo by Alex Green from Pexels
Photo by Alex Green from Pexels
Photo by Alex Green from Pexels
Photo by Alex Green from Pexels
Photo by Alex Green from Pexels
Lab & Pharmacy Supply Management

Johnson & Johnson reaches opioid settlement agreement with New York State

June 28, 2021
Johnson & Johnson and its U.S.-based Janssen Pharmaceutical Companies announced a settlement agreement with the State of New York and its participating subdivisions, including...
Photo by Thirdman from Pexels
Photo by Thirdman from Pexels
Photo by Thirdman from Pexels
Photo by Thirdman from Pexels
Photo by Thirdman from Pexels
Photo by Thirdman from Pexels
Lab & Pharmacy Supply Management

AdvaMed leader asks Administration to prioritize transport of medical supplies

June 25, 2021
President and CEO of AdvaMed Scott Whitaker sent a letter to President Biden on behalf of the medical technology industry asking “the Administration to make the transport of medical...
Lab & Pharmacy Supply Management

South African consortium to establish COVID mRNA vaccine technology transfer hub

June 22, 2021
The World Health Organization (WHO) announced it and its COVAX partners are working with a South African consortium comprising Biovac, Afrigen Biologics and Vaccines, a network...
Lab & Pharmacy Supply Management

GAO reports on Medicare spending on drugs with direct-to-consumer advertising

June 21, 2021
From 2016 to 2018, Medicare and its beneficiaries spent $560 billion on drugs—more than half on drugs that were advertised to encourage consumers to ask their doctors for specific...
Photo courtesy of Altarum
Photo courtesy of Altarum
Photo courtesy of Altarum
Photo courtesy of Altarum
Photo courtesy of Altarum
Photo courtesy of Altarum
Lab & Pharmacy Supply Management

New Alzheimer’s drug is projected to increase national health expenditures by more than one percent

June 17, 2021
Altarum released projections suggesting that, by the mid-2020s, Aduhelm, approved Aduhelm for treatment of Alzheimer’s disease on June 7 by the U.S. Food and Drug Administration...